Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...
With an in-line performance expected in Q3, ABT stock may trade sideways next week. However, we would watch out for its ...
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
Senseonics' Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by ...
(Reuters) - Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates ...
identifeye HEALTH, a medical diagnostics company at the forefront of AI and automation, is proud to announce the launch of the identifeye System, a retinal imaging camera designed to bring retinal ...
The Apple Watch has long been the Bad Bad Leroy Brown of smartwatches (baddest man in the whole damned town). The new Series ...
Abbott introduced FreeStyle Libre — a continuous glucose monitor now used by 6 million** people worldwide. Lingo is made by Abbott, built on that proven technology. *The Lingo system is not for ...